These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 30779121)

  • 1. Identification of DNA mutations in gastric washes from gastric adenocarcinoma patients: Possible implications for liquid biopsies and patient follow-up.
    Pizzi MP; Bartelli TF; Pelosof AG; Freitas HC; Begnami MD; de Abrantes LLS; Sztokfisz C; Valieris R; Knebel FH; Coelho LGV; da Costa WL; Coimbra FJF; da Silva IT; de Amorim MG; Nunes DN; Dias-Neto E
    Int J Cancer; 2019 Aug; 145(4):1090-1098. PubMed ID: 30779121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric Cancer.
    van Beek EJAH; Hernandez JM; Goldman DA; Davis JL; McLaughlin K; Ripley RT; Kim TS; Tang LH; Hechtman JF; Zheng J; Capanu M; Schultz N; Hyman DM; Ladanyi M; Berger MF; Solit DB; Janjigian YY; Strong VE
    Ann Surg Oncol; 2018 Jul; 25(7):2027-2033. PubMed ID: 29725898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of early genetic changes in well-differentiated intramucosal gastric carcinoma by target deep sequencing.
    Yoshida T; Yamaguchi T; Maekawa S; Takano S; Kuno T; Tanaka K; Iwamoto F; Tsukui Y; Kobayashi S; Asakawa Y; Shindo H; Fukasawa M; Nakayama Y; Inoue T; Uetake T; Ohtaka M; Sato T; Mochizuki K; Enomoto N
    Gastric Cancer; 2019 Jul; 22(4):742-750. PubMed ID: 30756200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis by next generation sequencing of gastric type dysplasia occurring in hyperplastic polyps of the stomach: Mutations in gastric hyperplastic polyps.
    Salomao M; Luna AM; Sepulveda JL; Sepulveda AR
    Exp Mol Pathol; 2015 Dec; 99(3):468-73. PubMed ID: 26325218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
    van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM
    Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation analysis by deep sequencing of pancreatic juice from patients with pancreatic ductal adenocarcinoma.
    Choi MH; Mejlænder-Andersen E; Manueldas S; El Jellas K; Steine SJ; Tjensvoll K; Sætran HA; Knappskog S; Hoem D; Nordgård O; Hovland R; Molven A
    BMC Cancer; 2019 Jan; 19(1):11. PubMed ID: 30611220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced MUTYH, MTH1, and OGG1 expression and TP53 mutation in diffuse-type adenocarcinoma of gastric cardia.
    Kohno Y; Yamamoto H; Hirahashi M; Kumagae Y; Nakamura M; Oki E; Oda Y
    Hum Pathol; 2016 Jun; 52():145-52. PubMed ID: 26980051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation between aneuploidy of chromosome 17, over-expression of TP53 and TOPIIalpha, and the clinicopathological features and diagnosis of gastric adenocarcinoma].
    Lu HZ; Wu YP; Luo W; Han YL; Cai Y; Xu X; Liang J; Liu SM; Wang MR
    Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):754-8. PubMed ID: 20021828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic mutation analysis of human gastric adenocarcinomas using ion torrent sequencing platform.
    Xu Z; Huo X; Ye H; Tang C; Nandakumar V; Lou F; Zhang D; Dong H; Sun H; Jiang S; Zhang G; Liu Z; Dong Z; Guo B; He Y; Yan C; Wang L; Su Z; Li Y; Gu D; Zhang X; Wu X; Wei X; Hong L; Zhang Y; Yang J; Gong Y; Tang C; Jones L; Huang XF; Chen SY; Chen J
    PLoS One; 2014; 9(7):e100442. PubMed ID: 25025766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers.
    Fassan M; Simbolo M; Bria E; Mafficini A; Pilotto S; Capelli P; Bencivenga M; Pecori S; Luchini C; Neves D; Turri G; Vicentini C; Montagna L; Tomezzoli A; Tortora G; Chilosi M; De Manzoni G; Scarpa A
    Gastric Cancer; 2014; 17(3):442-9. PubMed ID: 24272205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial and crucial genetic events in intestinal-type gastric intramucosal neoplasia.
    Rokutan H; Abe H; Nakamura H; Ushiku T; Arakawa E; Hosoda F; Yachida S; Tsuji Y; Fujishiro M; Koike K; Totoki Y; Fukayama M; Shibata T
    J Pathol; 2019 Apr; 247(4):494-504. PubMed ID: 30474112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of p53 gene mutation in the plasma of gastric cancer patients].
    Su PC; Zhang LH; Wan WH; Ren H; Zhang GG; Wang Y; Deng GR; Ji JF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):523-6. PubMed ID: 16224528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TP53 inactivation and expression of methylation-associated proteins in gastric adenocarcinoma with enteroblastic differentiation.
    Yatagai N; Saito T; Akazawa Y; Hayashi T; Yanai Y; Tsuyama S; Ueyama H; Murakami T; Watanabe S; Nagahara A; Yao T
    Virchows Arch; 2019 Mar; 474(3):315-324. PubMed ID: 30554333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Point mutation of TP53 suppressor gene in pre-neoplastic and neoplastic lesions of the stomach].
    Araya JC; Roa JC; Villaseca MA; Roa I; Guzmán P; Alvarado C; Melo A
    Rev Med Chil; 2003 Apr; 131(4):359-65. PubMed ID: 12870229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Near-Comprehensive Resequencing of Cancer-Associated Genes in Surgically Resected Metastatic Liver Tumors of Gastric Cancer.
    Ikari N; Serizawa A; Mitani S; Yamamoto M; Furukawa T
    Am J Pathol; 2019 Apr; 189(4):784-796. PubMed ID: 30703342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of liquid biopsies for detection of emerging mutated genes in metastatic colorectal cancer.
    Furuki H; Yamada T; Takahashi G; Iwai T; Koizumi M; Shinji S; Yokoyama Y; Takeda K; Taniai N; Uchida E
    Eur J Surg Oncol; 2018 Jul; 44(7):975-982. PubMed ID: 29452859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mutational burdens and evolutionary ages of early gastric cancers are comparable to those of advanced gastric cancers.
    Kim TM; Jung SH; Kim MS; Baek IP; Park SW; Lee SH; Lee HH; Kim SS; Chung YJ; Lee SH
    J Pathol; 2014 Nov; 234(3):365-74. PubMed ID: 25042771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of p53 mutations in esophageal and gastric carcinomas and the relationship with p53 expression.
    Hanazono K; Natsugoe S; Stein HJ; Aikou T; Hoefler H; Siewert JR
    Oncol Rep; 2006 Apr; 15(4):821-4. PubMed ID: 16525665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation spectrum of TP53 gene predicts clinicopathological features and survival of gastric cancer.
    Tahara T; Shibata T; Okamoto Y; Yamazaki J; Kawamura T; Horiguchi N; Okubo M; Nakano N; Ishizuka T; Nagasaka M; Nakagawa Y; Ohmiya N
    Oncotarget; 2016 Jul; 7(27):42252-60. PubMed ID: 27323394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation of TP53 and alteration of p14(arf) expression in EGFR- and KRAS-mutated lung adenocarcinomas.
    Cortot AB; Younes M; Martel-Planche G; Guibert B; Isaac S; Souquet PJ; Commo F; Girard P; Fouret P; Brambilla E; Hainaut P; Soria JC
    Clin Lung Cancer; 2014 Mar; 15(2):124-30. PubMed ID: 24169260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.